Literature DB >> 27077770

Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals.

Rajiv Yadav1, Monica Lazarus2, Pawan Ghanghoria2, Mpss Singh1, Rasik Behari Gupta1, Surendra Kumar1, Ravendra K Sharma1, Rajasubramaniam Shanmugam1.   

Abstract

BACKGROUND AND OBJECTIVES: The clinical manifestation in sickle cell disease (SCD) patients varies from one individual to another due to factors like the presence of alpha-thalassaemia mutation, foetal haemoglobin, and β-globin gene haplotype. The present study enumerates the clinical profile of sickle cell anaemia patients from Central India.
METHODS: Seven hundred seventy-six SCD patients from Jabalpur and surrounding districts (Madhya Pradesh) in central India were registered with the sickle cell clinic of NIRTH, Jabalpur. The present study reveals recorded signs and symptoms of genetically confirmed sickle cell anaemia (404) and sickle beta thalassaemia (92) patients.
RESULTS: Majority of the patients were from scheduled caste communities (47.9%) and Gond tribal community (13.8%). Splenomegaly was the most common clinical manifestation observed (71.4%). Overall, 63.5% patients had a history of blood transfusion. The most frequent signs and symptoms observed were Pallor, Icterus, Joint pain, Fever, and Fatigue. Majority of the patients revealed onset of disease prior to attaining the age of 3 years (sickle cell anaemia 44.3% and sickle beta thalassaemia 35.9%). Mean haemoglobin levels among SCA individuals were marginally higher than SBT patients. On the other hand, mean foetal haemoglobin levels among SBT individuals showed the reverse trend. Notably, the present study reports the first incidence of priapism recorded in Central India.
CONCLUSIONS: The study revealed a high prevalence of SCD among scheduled caste, backward caste, and tribal communities. Dissemination of study findings, screening, pre-marriage counselling, and pre-natal diagnosis are fundamental to preventing or lowering of birth of sickle cell anaemia children in the affected populations.

Entities:  

Keywords:  Madhya Pradesh; Sickle cell disease

Mesh:

Year:  2016        PMID: 27077770     DOI: 10.1080/10245332.2016.1148893

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  5 in total

1.  Sickle cell disease in Sri Lanka: clinical and molecular basis and the unanswered questions about disease severity.

Authors:  Thamal Darshana; Dayananda Bandara; Upul Nawarathne; Udaya de Silva; Yasinta Costa; Kalavitigoda Pushpakumara; Sumithra Pathirage; Seuwandi Basnayake; Chamila Epa; Pradeepa Dilrukshi; Maheshaka Wijayawardena; Angela A Anthony; Rexan Rodrigo; Aresha Manamperi; Frances Smith; Angela Allen; Stephan Menzel; David Rees; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2020-07-06       Impact factor: 4.123

Review 2.  Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease.

Authors:  Thamal Darshana; David Rees; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

3.  Difficulties in the diagnosis of HbS/beta thalassemia: Really a mild disease?

Authors:  Süheyl Uçucu; Talha Karabıyık; Fatih Azik
Journal:  J Med Biochem       Date:  2022-02-02       Impact factor: 3.402

4.  An Analysis of Maternal, Social and Household Factors Associated with Childhood Anemia.

Authors:  Vidya Chandran; Russell S Kirby
Journal:  Int J Environ Res Public Health       Date:  2021-03-17       Impact factor: 3.390

5.  β-Thalassemia pathogenic variants in a cohort of children from the East African coast.

Authors:  Alexander W Macharia; George Mochamah; Sophie Uyoga; Carolyne M Ndila; Gideon Nyutu; Metrine Tendwa; Emily Nyatichi; Johnstone Makale; Russell E Ware; Thomas N Williams
Journal:  Mol Genet Genomic Med       Date:  2020-05-11       Impact factor: 2.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.